FDA Approves Zanvastro (zilganersen) for the Treatment of Alexander Disease

Sep 7, 2026 - 06:00
 0  0
CARLSBAD, Calif.--(BUSINESS WIRE)--September 3, 2026-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved Zanvastro (zilganersen) for the treatment of Alexander disease (AxD) in...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0